<DOC>
	<DOCNO>NCT01056380</DOCNO>
	<brief_summary>This randomize clinical trial design evaluate oral nitazoxanide compare placebo treatment acute uncomplicated influenza adult . We hypothesize treatment nitazoxanide reduce duration symptom patient confirm influenza infection . Secondarily , hypothesize treatment nitazoxanide reduce complication influenza , severity symptom , time lose work , time return normal daily activity , viral shedding .</brief_summary>
	<brief_title>Study Nitazoxanide Adults With Acute Uncomplicated Influenza</brief_title>
	<detailed_description>The study conduct approximately 25 site United States . Subjects select base symptom randomize receive oral nitazoxanide placebo twice daily 5 day . Subjects monitor daily telephone home visit monitor symptoms complication influenza safety refer medical care require . Subjects complete diary twice daily record presence severity symptom , ability perform normal daily activity time lose work . Complications influenza ( include sinusitis , otitis , bronchitis , pneumonia , central nervous system disease ) adverse event report . Nasopharyngeal swab collect Baseline ( Day 0 ) Day 7 patient Days 1 4 subset patient test influenza A ( include novel H1N1 ) , influenza B 17 respiratory virus RT-PCR culture evaluate quantitative viral shed . The primary analysis patient confirm influenza , secondary analysis conduct subject respiratory virus treat subject .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<criteria>Age 18 65 year Fever , respiratory symptom constitutional symptom compatible influenza infection Influenza A B infection local community Onset illness 48 hour presentation Willing able provide comply protocol requirement Severity illness require anticipate require inhospital care High risk complication influenza per IDSA guideline current CDC criterion Females pregnant , breastfeed sexually active without birth control Vaccination seasonal influenza H1N1 August 1 , 2009 Treatment antiviral medication influenza within 1 month prior screen Treatment nitazoxanide investigational drug within 1 month prior screen Known sensitivity nitazoxanide excipients Unable take oral medication Chronic kidney liver disease know impaired hepatic and/or renal function Other preexist chronic infection undergo require medical therapy Preexisting illness place subject unreasonably increase risk participation study Unlikely comply requirement protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>influenza</keyword>
	<keyword>influenza like illness</keyword>
</DOC>